Skip to search formSkip to main content

NC 531

Known as: NC-531, NC531 cpd 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?
Review
2004
Review
2004
  • Hugo Geerts
  • Current opinion in investigational drugs
  • 2004
NC-531 is a sulfated glycosaminoglycan mimetic that inhibits amyloid plaque formation, and is under development by Neurochem for… Expand
Is this relevant?
2004
2004
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?